By Atish S. Mundada, Alap Chaudhari Novel Drug Delivery Systems – Part 1 provides a comprehensive exploration of controlled drug delivery systems (NDDS) and their impact on patient outcomes and therapeutic effectiveness. Covering key topics like the principles of controlled-release dosage forms, the role of polymers, and innovative techniques like microencapsulation and mucoadhesive systems, this book bridges foundational concepts with cutting-edge advancements. It also addresses specialized systems like gastroretentive, transdermal, and ocular drug delivery methods. Ideal for pharmaceutical professionals, students, and researchers, this book serves as a critical resource for understanding and developing advanced drug delivery technologies.Key Features:- Comprehensive introduction to controlled drug delivery concepts- In-depth analysis of pharmacokinetics and polymers in NDDS- Exploration of microencapsulation and mucoadhesive systems- Insights into gastroretentive and transdermal drug delivery- Overview of nanotechnology and implantable devices in drug delivery- Coverage of the latest developments in injectables and ocular systems
Novel Drug Delivery Systems (Part 1) (PDF)
7 $
Format: Publisher PDF
File Size : 43.3 MB
Publication Year: 2024
Be the first to review “Novel Drug Delivery Systems (Part 1) (PDF)” Cancel reply
You must be logged in to post a review.
Related Products
Medical Book
AngelsVR 2nd Beatufication Endoscopic Face & Closed Rhinoplasty Live Surgery Course 2022
Medical Book
UChicago Medicine John F. Gilmore Symposium on Nutrition and Small Bowel Disorders 2024
Medical Book
Advancements in Cancer Research: Exploring Diagnostics and Therapeutic Breakthroughs (EPUB)
Medical Book
Advancements in Cancer Research: Exploring Diagnostics and Therapeutic Breakthroughs (PDF)
Medical Book
A Case-Based Approach to Interventional Pulmonology: A Focus on Asian Perspectives (EPUB)
Medical Book
Lifestyle Diseases in Adolescents: Addressing Physical, Emotional, and Behavioral Issues (EPUB)
Reviews
There are no reviews yet.